GSK Investigational Site

Christiansburg, Virginia 24073

0 studies enrolling now · 8 studies all time

What they study most

Bipolar Disorder, Bowel Dysfunction, Constipation, Crohn's Disease, Hypertension, Irritable Bowel Syndrome (IBS), Irritable Colon

Studies at this site

• An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease — Stopped early
• Open-Label Extension Study of GSK1605786A — Stopped early
• GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease — Stopped early
• Bipolar Study in Adults at Least 18 Years of Age — Completed
• Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain — Completed
• Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy — Completed
• Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension — Completed
• Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS) — Completed